Literature DB >> 33475753

Association of Obstructive Sleep Apnea With the Risk of Male Infertility in Taiwan.

Yi-Han Jhuang1, Chi-Hsiang Chung2,3,4, I-Duo Wang5, Chung-Kan Peng5, En Meng6, Wu-Chien Chien2,3,4,7, Ping-Ying Chang8.   

Abstract

Importance: Obstructive sleep apnea (OSA) has been proposed as a risk factor in infertility. However, to date, the association between OSA and male infertility has not been examined in a population-based study. Objective: To investigate the risk factor of OSA in male infertility and the outcome of OSA treatment for the risk of male infertility. Design, Setting, and Participants: This case-control population-based study collected data from the Longitudinal Health Insurance Database, a subset of the National Health Insurance Research Database in Taiwan. Male patients with a diagnosis of infertility and at least 3 outpatient visits or 1 hospitalization between January 1, 2000, and December 31, 2013, were included and matched by age, sex, and date of infertility diagnosis with individuals without an infertility diagnosis. Data analysis was performed from October 22, 2018, to April 22, 2019. Exposures: Patients with male infertility and randomly selected patients without male infertility were matched using a 1:4 propensity score matching ratio. Main Outcomes and Measures: A primary outcome was the risk factor of OSA (diagnosed through polysomnography). A secondary outcome was the association of the risk of male infertility with OSA exposure time interval (short term, middle term, and long term) and OSA management (ie, none, continuous positive airway pressure, uvulopalatopharyngoplasty, or both).
Results: A total of 4607 male patients with infertility (mean [SD] age, 34.18 [5.44] years) and 18 428 control patients (mean [SD] age, 34.28 [5.81] years) were included. In the multivariate conditional logistic regression analysis, OSA was an independent risk factor associated with infertility (adjusted odds ratio [OR], 1.24; 95% CI, 1.10-1.64; P = .003). The absolute risk was 0.204 (95% CI, 0.092-0.391). For patients with OSA in the group without treatment, the adjusted OR was 1.80 (95% CI, 1.56-2.07; P < .001) for infertility compared with patients without OSA. Conclusions and Relevance: Results of this study support the hypothesis that OSA increases the risk of infertility in male patients, and the risk is associated with the OSA exposure time. Furthermore, no OSA management or treatment is associated with a higher infertility risk.

Entities:  

Mesh:

Year:  2021        PMID: 33475753      PMCID: PMC7821032          DOI: 10.1001/jamanetworkopen.2020.31846

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  33 in total

Review 1.  The epidemiology of male infertility.

Authors:  Brian R Winters; Thomas J Walsh
Journal:  Urol Clin North Am       Date:  2013-09-13       Impact factor: 2.241

2.  Reversible reproductive dysfunction in men with obstructive sleep apnoea.

Authors:  J D Santamaria; J C Prior; J A Fleetham
Journal:  Clin Endocrinol (Oxf)       Date:  1988-05       Impact factor: 3.478

3.  International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care.

Authors:  Jacky Boivin; Laura Bunting; John A Collins; Karl G Nygren
Journal:  Hum Reprod       Date:  2007-03-21       Impact factor: 6.918

4.  Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

Authors:  Takuya Yokoe; Kenji Minoguchi; Hirofumi Matsuo; Naruhito Oda; Hideko Minoguchi; Gen Yoshino; Tsutomu Hirano; Mitsuru Adachi
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

5.  Relationship between seminal plasma interleukin-6 and tumor necrosis factor alpha levels with semen parameters in fertile and infertile men.

Authors:  Izzet Koçak; Cigdem Yenisey; Mehmet Dündar; Pinar Okyay; Mukadder Serter
Journal:  Urol Res       Date:  2002-06-27

6.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

Review 7.  The relationship of obesity and obstructive sleep apnea.

Authors:  Neomi Shah; Francoise Roux
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

8.  Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea.

Authors:  N Meston; R J O Davies; R Mullins; C Jenkinson; J A H Wass; J R Stradling
Journal:  J Intern Med       Date:  2003-11       Impact factor: 8.989

Review 9.  Linking sleep disturbance to idiopathic male infertility.

Authors:  Gaurie Palnitkar; Craig L Phillips; Camilla M Hoyos; Anthony J Marren; Mark C Bowman; Brendon J Yee
Journal:  Sleep Med Rev       Date:  2018-08-03       Impact factor: 11.609

Review 10.  Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.

Authors:  Hans-Joachim Eisele; Philipp Markart; Richard Schulz
Journal:  Oxid Med Cell Longev       Date:  2015-06-08       Impact factor: 6.543

View more
  4 in total

1.  Errors in Table 3.

Authors: 
Journal:  JAMA Netw Open       Date:  2022-07-01

Review 2.  Erectile Dysfunction and Obstructive Sleep Apnea: A Review.

Authors:  Yiwei Gu; ChangJing Wu; Feng Qin; Jiuhong Yuan
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

3.  Obstructive Sleep Apnea Affects Lacrimal Gland Function.

Authors:  Shaopan Wang; Xin He; Qingmin Li; Yuhan Zhang; Jiaoyue Hu; Rongrong Zong; Jingyi Zhuang; Andrew J Quantock; Yingying Gao; Wei Li; Zuguo Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

4.  Risk of Infertility in Males with Obstructive Sleep Apnea: A Nationwide, Population-Based, Nested Case-Control Study.

Authors:  Pin-Yao Lin; Hua Ting; Yen-Ting Lu; Jing-Yang Huang; Tsung-Hsien Lee; Maw-Sheng Lee; James Cheng-Chung Wei
Journal:  J Pers Med       Date:  2022-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.